Oral Semaglutide's Cardiovascular Outcomes in Type 2 Diabetes Explored by Vascular Disease Extent
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease.
Abstract
Oral semaglutide's impact on cardiovascular outcomes in Type 2 Diabetes, stratified by existing vascular disease, is the focus of this investigation.